← Open Payments lookup

KELLY FOREIT: Open Payments

NPI 1992569107 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$646 in 41 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $288 · 2025 $646

Food & beverage: $646
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$179
Novo Nordisk Inc14$145
Lilly USA, LLC8$126
ABBVIE INC.3$50
Axsome Therapeutics, Inc.1$27
Otsuka America Pharmaceutical, Inc.1$23
Bayer Healthcare Pharmaceuticals Inc.1$18
Abbott Laboratories1$17
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17
Phathom Pharmaceuticals, Inc.2$15

Products named: MOUNJARO, AIRSUPRA, Ozempic, FARXIGA, UBRELVY, Wegovy, Auvelity, REXULTI.

Industry payments across IN — which companies pay providers there.